Position in MRK
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$3,289,985
+$476,402 QoQ
Shares Held
25,603
+9.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.62%
of 13F equity value
Holder Rank
#1,284
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MITCHELL MCLEOD PUGH & WILLIAMS INC holds $30,637,991 across 10 Drug Manufacturers - General names. MRK ranks #4 (10.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,466 | $8,954,945 | |
| 2 | JNJ |
Johnson & Johnson
|
28,718 | $7,293,509 | |
| 3 | ABBV |
AbbVie Inc.
|
20,243 | $5,093,948 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
25,603 | $3,289,985 | |
| 5 | PFE |
Pfizer Inc
|
69,337 | $1,669,634 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
19,456 | $1,121,054 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
8,716 | $1,101,179 | |
| 8 | AMGN |
Amgen Inc
|
2,634 | $953,824 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,289,985 | 25,603 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $2,813,583 | 23,390 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $2,383,717 | 22,646 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1,912,261 | 22,784 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $1,879,891 | 23,748 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $2,084,047 | 23,218 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $2,329,722 | 23,419 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $2,639,247 | 23,241 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $2,832,420 | 22,879 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $2,995,924 | 22,705 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $2,498,084 | 22,914 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $2,381,851 | 23,136 | Shares | Sole | 2023-10-20 | |
| 2023-06-30 | $2,597,082 | 22,507 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $2,406,541 | 22,620 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $2,495,931 | 22,496 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $1,881,291 | 21,845 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $1,774,806 | 19,467 | Shares | Sole | 2022-11-18 | |
| 2022-03-31 | $1,583,565 | 19,300 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $1,455,163 | 18,987 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $1,363,396 | 18,152 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $1,401,570 | 18,022 | Shares | Sole | 2021-11-08 | |
| 2021-03-31 | $1,318,933 | 17,109 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $1,367,368 | 16,716 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $1,388,416 | 16,738 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $1,239,213 | 16,025 | Shares | Sole | 2020-07-17 | |
| 2020-03-31 | $992,140 | 12,895 | Shares | Sole | 2020-04-08 | |
| No filing history on record for this holder in this stock. | ||||||